Calamos Advisors’s iRadimed IRMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $530K | Buy |
8,867
+4,389
| +98% | +$262K | ﹤0.01% | 699 |
|
|
2025
Q1 | $235K | Sell |
4,478
-118
| -3% | -$6.19K | ﹤0.01% | 749 |
|
|
2024
Q4 | $253K | Sell |
4,596
-435
| -9% | -$23.9K | ﹤0.01% | 750 |
|
|
2024
Q3 | $253K | Buy |
+5,031
| New | +$253K | ﹤0.01% | 745 |
|
|
2024
Q2 | – | Sell |
-5,073
| Closed | -$223K | – | 936 |
|
|
2024
Q1 | $223K | Sell |
5,073
-30,129
| -86% | -$1.33M | ﹤0.01% | 740 |
|
|
2023
Q4 | $1.67M | Sell |
35,202
-735
| -2% | -$34.9K | 0.01% | 585 |
|
|
2023
Q3 | $1.59M | Buy |
35,937
+3,000
| +9% | +$133K | 0.01% | 605 |
|
|
2023
Q2 | $1.57M | Buy |
32,937
+1,728
| +6% | +$82.5K | 0.01% | 646 |
|
|
2023
Q1 | $1.23M | Buy |
31,209
+18,552
| +147% | +$730K | 0.01% | 759 |
|
|
2022
Q4 | $358K | Sell |
12,657
-60,105
| -83% | -$1.7M | ﹤0.01% | 894 |
|
|
2022
Q3 | $2.19M | Sell |
72,762
-7,705
| -10% | -$232K | 0.01% | 829 |
|
|
2022
Q2 | $2.73M | Sell |
80,467
-7,099
| -8% | -$241K | 0.01% | 829 |
|
|
2022
Q1 | $3.93M | Buy |
87,566
+17,822
| +26% | +$799K | 0.01% | 769 |
|
|
2021
Q4 | $3.22M | Buy |
+69,744
| New | +$3.22M | 0.01% | 769 |
|
|
2019
Q1 | – | Sell |
-11,740
| Closed | -$287K | – | 638 |
|
|
2018
Q4 | $287K | Hold |
11,740
| – | – | ﹤0.01% | 584 |
|
|
2018
Q3 | $436K | Buy |
+11,740
| New | +$436K | ﹤0.01% | 553 |
|